STAAR Surgical (STAA) Tops Q3 EPS by 10c, Revenues Beat; 'Raises Outlook for Full Year 2018'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St mixed as benchmark Treasury yields reach 5%, oil takes a pause
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
STAAR Surgical ICL Sales Up 46%; Company Raises Outlook for Full Year 2018
October 31, 2018 4:01 PM EDTMONROVIA, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended September 28, 2018.
Third Quarter 2018 Overview
Net Sales of $31.8 Million Up 35% from the Prior Year Quarter ICL Sales Up 46% and Units Up 56% from the Prior Year Quarter Gross Margin at 75.1% of Sales from 71.8% of Sales in the Prior Year Quarter... More